2008
Efficacy of Clobazam as Add-on Therapy for Refractory Epilepsy
Montenegro MA, Arif H, Nahm EA, Resor SR, Hirsch LJ. Efficacy of Clobazam as Add-on Therapy for Refractory Epilepsy. Clinical Neuropharmacology 2008, 31: 333-338. PMID: 19050410, DOI: 10.1097/wnf.0b013e31815cd960.Peer-Reviewed Original ResearchConceptsRefractory epilepsyEpilepsy centersColumbia Comprehensive Epilepsy CenterAntiepileptic drug regimenEfficacy of clobazamIntroduction of clobazamUS epilepsy centersUse of clobazamMultiple seizure typesComprehensive Epilepsy CenterAntiepileptic drug trialsPopulation of patientsAddition of clobazamMeasures of efficacyBinary logistic regressionDrug regimenSeizure freedomSeizure typesKaplan-MeierUS CentersDrug trialsPatientsUS FoodClobazamDrug Administration
2002
Levetiracetam May Be More Effective for Late-Onset Partial Epilepsy
Bazil CW, Rose A, Resor S, Yapicular B, Hirsch LJ. Levetiracetam May Be More Effective for Late-Onset Partial Epilepsy. JAMA Neurology 2002, 59: 1905-1908. PMID: 12470178, DOI: 10.1001/archneur.59.12.1905.Peer-Reviewed Original ResearchConceptsLevetiracetam therapySeizure typesRetrospective medical record reviewFrontal lobe onsetSame seizure typesTemporal lobe onsetLarge prospective trialsMedical record reviewSubset of patientsPopulation of patientsLocalization-related epilepsyNew antiepileptic drugsProspective trialRefractory epilepsyRecord reviewAntiepileptic drugsPartial epilepsySignificant worseningDrug choiceClinical experiencePatientsEpileptic seizuresEpilepsyCertain drugsCertain subpopulations